713 reports of this reaction
1.4% of all TAPENTADOL HYDROCHLORIDE reports
#9 most reported adverse reaction
NAUSEA is the #9 most commonly reported adverse reaction for TAPENTADOL HYDROCHLORIDE, manufactured by Collegium Pharmaceutical, Inc.. There are 713 FDA adverse event reports linking TAPENTADOL HYDROCHLORIDE to NAUSEA. This represents approximately 1.4% of all 50,606 adverse event reports for this drug.
TAPENTADOL HYDROCHLORIDE has an overall safety score of 92 out of 100. Patients taking TAPENTADOL HYDROCHLORIDE who experience nausea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
NAUSEA is a less commonly reported adverse event for TAPENTADOL HYDROCHLORIDE, but still significant enough to appear in the safety profile.
In addition to nausea, the following adverse reactions have been reported for TAPENTADOL HYDROCHLORIDE:
The following drugs have also been linked to nausea in FDA adverse event reports:
NAUSEA has been reported as an adverse event in 713 FDA reports for TAPENTADOL HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
NAUSEA accounts for approximately 1.4% of all adverse event reports for TAPENTADOL HYDROCHLORIDE, making it a notable side effect.
If you experience nausea while taking TAPENTADOL HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.